All three patients received pacemaker implantation, resulting in the symptoms of severe bradycardia disappearing.<h4>Conclusion</h4><i>SCN5A</i> heterozygous mutations are common among patients clinically affected by SSS. The gene discussed is SCN5A; the disease is Bradycardia.